The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SOLTI-2201 ACROSS-TROP2 trial: A phase II study to identify predictive biomarkers of sacituzumab govitecan benefit and to understand resistance mechanisms in HR+/HER2- advanced or metastatic breast cancer.
 
Eva Ciruelos
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Menarini Group; MSD Oncology; Novartis; Novartis; Pfizer; Reveal Genomics; Reveal Genomics; Roche; Seagen
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Lilly; MSD Oncology; Roche
Research Funding - Pfizer; Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Tomás Pascual
Honoraria - Argenetics; AstraZeneca; Gilead Sciences; Lilly; Novartis; Veracyte
Consulting or Advisory Role - Novartis; Roche/Genentech
Speakers' Bureau - AstraZeneca; Novartis; Pfizer; Veracyte
Travel, Accommodations, Expenses - Gilead Sciences
 
Isabel Blancas
Honoraria - AstraZeneca Spain; Bristol Myers Squibb; Daiichi Sankyo/Astra Zeneca; Eisai; Gilead Sciences; GlaxoSmithKline; Grunenthal; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen; Veracyte; Veracyte
Consulting or Advisory Role - AstraZeneca Spain; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Eisai; Lilly; Novartis; Pfizer; Pierre Fabre; Roche; Veracyte
Research Funding - Agendia (Inst); AstraZeneca Spain (Inst); Lilly; Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Lilly; Novartis; Pfizer; Pierre Fabre; Roche
Other Relationship - Fundación San Juan de Dios; Medical Science Innovation Research (MEDSIR)
 
Maria Borrell
No Relationships to Disclose
 
Rafael Villanueva-Vázquez
Consulting or Advisory Role - AstraZeneca; Seagen
Travel, Accommodations, Expenses - AstraZeneca Spain; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Novartis
 
Barbara Adamo
No Relationships to Disclose
 
Manuel Alva Bianchi
No Relationships to Disclose
 
Lidia Córdoba
Consulting or Advisory Role - Menarini
Speakers' Bureau - AstraZeneca Spain; Gilead Sciences; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Novartis
 
Mireia Melé Olivé
No Relationships to Disclose
 
Juan Miguel Cejalvo
No Relationships to Disclose
 
Javier Bofill
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Lilly; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - Pfizer
 
Angelica Ferrando-Diez
No Relationships to Disclose
 
Yann Izarzugaza Peron
No Relationships to Disclose
 
Aranzazu Fernández
No Relationships to Disclose
 
Xavier Gonzalez
Expert Testimony - Novartis; Pierre Fabre
Travel, Accommodations, Expenses - AstraZeneca
 
Guillermo Villacampa
Honoraria - Reveal Genomics
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline
Speakers' Bureau - MSD Oncology; Pfizer; Pierre Fabre
 
Mariana Paes Dias
No Relationships to Disclose
 
Juan Manuel Ferrero-Cafiero
No Relationships to Disclose
 
Mafalda Oliveira
Honoraria - AstraZeneca; Curio Science; Eisai; Gilead Sciences; i-One; Libbs; Lilly; MSD
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; MSD; Pfizer; ProteinQure; Relay Therapeutics; Roche
Research Funding - AstraZeneca (Inst); Gilead Sciences (Inst); Immutep (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Eisai; Gilead Sciences; Roche
(OPTIONAL) Uncompensated Relationships - President elected, SOLTI Cancer Research Group